In multiple sclerosis, the ability of clinicians to provide a prognosis for a patient and the design and interpretation of clinical trials both rely heavily on prognostic factors identified from ...

The landscape of gMG treatment is rapidly evolving, said John Morren, MD, of the Cleveland Clinic. The traditional approach ...

Relapsing Multiple Sclerosis: Navigating Treatment Conundrums This activity is supported by an educational grant from Novartis Pharmaceuticals, Inc.

Although certain diets are sometimes touted as solutions for multiple sclerosis, they often lack evidence to support their claims, one expert says.

Multiple sclerosis (MS) is a major, immune-mediated, demyelinating disease and the major cause of non-traumatic disability in young adults. Susceptibility to disease is controlled by a variety of ...

Background/aims Current understanding of the alterations in the retinal vascular network in neuromyelitis optica spectrum disorders (NMOSDs) is limited. We aim to assess the peripapillary and ...

Introduction Neuromyelitis optica spectrum disorders (NMOSD) are autoantibody-induced inflammatory diseases of the central nervous system, characterized by recurrent optic neuritis (ON) and transverse ...

Acute demyelinating optic neuritis (referred to herein as optic neuritis) is one of the most common manifestations of MS and often occurs as a first demyelinating event. Patients present with loss ...

In multiple sclerosis (MS), diffuse degenerative processes in the deep grey matter have been associated with clinical disabilities. We performed a systematic study in MS deep grey matter with a focus ...

More information: Kelley C. Atkinson et al, Decreased mitochondrial activity in the demyelinating cerebellum of progressive multiple sclerosis and chronic EAE contributes to Purkinje cell loss ...

Multiple sclerosis is a neurological disorder that occurs when the immune system mistakenly attacks the protective sheath surrounding the nerves in the brain and spinal cord. This causes inflammation ...

Neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) have a negative impact on employment, a study found.